rBMP represses Wnt signaling and influences skeletal progenitor cell fate specification during bone repair

Journal of Bone and Mineral Research

Volumn 25, Issue 6, 2010, Pages 1196-1207

  Minear, Steve ^a   Leucht, Philipp ^a   Miller, Samara ^a   Helms, Jill A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone morphogenetic proteins; Molecular; Regeneration; Repair; Signaling; Wnt

Indexed keywords

ALKALINE PHOSPHATASE; BETA CATENIN; BONE MORPHOGENETIC PROTEIN; COLLAGEN TYPE 1; SMAD PROTEIN; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9; WNT PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MARROW CELL; BONE REMODELING; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROGENESIS; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; MOUSE; NONHUMAN; OSTEOBLAST; PERIOSTEUM; PHOSPHORYLATION; PLEIOTROPY; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; BONE MARROW; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINEAGE; CHONDROCYTES; CHORISTOMA; MICE; ORGAN SPECIFICITY; OSTEOBLASTS; OSTEOGENESIS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; STEM CELLS; UP-REGULATION; WNT PROTEINS; WOUND HEALING;

EID: 77952966866     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.29     Document Type: Article

References (72)

1. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 2002;16:2813-2828. (Pubitemid 35253149)
2. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997;89:747-754. (Pubitemid 27516177)
3. Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997;89:755-764. (Pubitemid 27516178)
4. Kobayashi T, Lu J, Cobb BS, et al. Dicer-dependent pathways regulate chondrocyte proliferation and differentiation. Proc Natl Acad Sci U S A. 2008;105:1949-1954. (Pubitemid 351439445)
5. Vortkamp A, Lee K, Lanske B, Segre GV, Kronenberg HM, Tabin CJ. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science. 1996;273:613-622. (Pubitemid 26262108)
6. St-Jacques B, Hammerschmidt M, McMahon AP. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes and Development. 1999;13:2072-2086. (Pubitemid 29407348)
7. Lanske B, Karaplis AC, Lee K, et al. PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth (see comments). Science. 1996;273:663-666. (Pubitemid 26262123)
8. Farber CR, van Nas A, Ghazalpour A, et al. An integrative genetics approach to identify candidate genes regulating BMD: combining linkage, gene expression, and association. J Bone Miner Res. 2009;24:105-116.
9. Vaes BL, Dechering KJ, Feijen A, et al. Comprehensive microarray analysis of bone morphogenetic protein 2-induced osteoblast differentiation resulting in the identification of novel markers for bone development. J Bone Miner Res. 2002;17:2106-2118. (Pubitemid 35416746)
10. James CG, Appleton CT, Ulici V, Underhill TM, Beier F. Microarray analyses of gene expression during chondrocyte differentiation identifies novel regulators of hypertrophy. Mol Biol Cell. 2005;16:5316-5333. (Pubitemid 41566842)
11. Pogue R, Lyons K. BMP signaling in the cartilage growth plate. Curr Top Dev Biol. 2006;76:1-48. (Pubitemid 44760537)
12. Urist MR. Bone: Formation by autoinduction. Science. 1965;150:893.
13. Urist MR, Silverman BF, Buring K, Dubuc FL, Rosenberg JM. The bone induction principle. Clin Orthop. 1967;53:243-283.
14. Hall BK, Miyake T. Divide, accumulate, differentiate: cell condensation in skeletal development revisited. International Journal of Developmental Biology. 1995;39:881-893. (Pubitemid 26097613)
15. Retting KN, Song B, Yoon BS, Lyons KM. BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation. Development. 2009;136:1093-1104.
16. Schmidl M, Adam N, Surmann-Schmitt C, et al. Twisted gastrulation modulates bone morphogenetic protein-induced collagen II and X expression in chondrocytes in vitro and in vivo. J Biol Chem. 2006;281:31790-31800. (Pubitemid 46041444)
17. Kamiya N, Ye L, Kobayashi T, et al. BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. Development. 2008;135:3801-3811.
18. Govender S, Csimma C, Genant HK, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002;84-:2123-2134. (Pubitemid 35417689)
19. Cook SD, Baffes GC, Wolfe MW, Sampath TK, Rueger DC. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segemental defect model. CORR. 1994;301:302-312.
20. Salkeld SL, Patron LP, Barrack RL, Cook SD. The effect of osteogenic protein-1 on the healing of segmental bone defects treated with autograft or allograft bone. J Bone Joint Surg Am. 2001;83-A:803-816.
21. Gautschi OP, Frey SP, Zellweger R. Bone morphogenetic proteins in clinical applications. Aust NZ J Surg. 2007;77:626-631. (Pubitemid 47063348)
22. Armstrong D, Burton TM. Medtronic Product Linked to Surgery Problems Wall Street Journal. Wall Street Journal, New York City. 2008.
23. Dimitriou R, Dahabreh Z, Katsoulis E, Matthews SJ, Branfoot T, Giannoudis PV. Application of recombinant BMP-7 on persistent upper and lower limb non-unions. Injury. 2005;36 (Suppl 4): S51-59.
24. Friedlaender GE, Perry CR, Cole JD, et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am. 2001;83-A (Suppl 1): S151-158.
25. Kanayama M, Hashimoto T, Shigenobu K, Yamane S, Bauer TW, Togawa D. A prospective randomized study of posterolateral lumbar fusion using osteogenic protein-1 (OP-1) versus local autograft with ceramic bone substitute: emphasis of surgical exploration and histologic assessment. Spine. 2006;31:1067-1074.
26. Welch RD, Jones AL, Bucholz RW, et al. Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model. Journal of Bone and Mineral Research. 1998;13:1483-1490.
27. Jeppsson C, Aspenberg P. BMP-2 can inhibit bone healing. Bone-chamber study in rabbits. Acta Orthop Scand. 1996;67:589-592.
28. Gerhart TN, Kirker-Head CA, Kriz MJ, et al. Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin Orthop. 1993;293:317-326.
29. Oni OO, Gregg PJ. An investigation of the contribution of the extraosseous tissues to the diaphyseal fracture callus using a rabbit tibial fracture model. J Orthop Trauma. 1991;5:480-484.
30. Sacco A, Doyonnas R, Kraft P, Vitorovic S, Blau HM. Self-renewal and expansion of single transplanted muscle stem cells. Nature. 2008;456:502-506. (Pubitemid 50278031)
31. Modder UI, Khosla S. Skeletal stem/osteoprogenitor cells: current concepts, alternate hypotheses, and relationship to the bone remodeling compartment. J Cell Biochem. 2008;103:393-400. (Pubitemid 351171911)
32. Lustig B, Jerchow B, Sachs M, et al. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol. 2002;22:1184-1193. (Pubitemid 34094854)
33. Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. Wnt/β-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol. 2002;22:1172-1183. (Pubitemid 34094853)
34. Kim JB, Leucht P, Lam K, et al. Bone regeneration is regulated by Wnt signaling. J Bone Miner Res. 2007;22:1913-1923. (Pubitemid 351229308)
35. Leucht P, Kim JB, Helms JA. Beta-catenin-dependent Wnt signaling in mandibular bone regeneration. J Bone Joint Surg Am. 2008;90 (Suppl 1): 3-8.
36. Leucht P, Kim J-B, Amasha RR, Girod SA, Helms JA. Embryonic origin and Hox status determine progenitor cell fate during adult bone regeneration. Development. 2008;135:2845-2854.
37. Zellin G, Linde A. Effects of recombinant human fibroblast growth factor-2 on osteogenic cell populations during orthopic osteogenesis in vivo. Bone. 2000;26:161-168. (Pubitemid 30029209)
38. Bouxsein ML, Turek TJ, Blake CA, et al. Recombinant human bone morphogenetic protein-2 accelerates healing in a rabbit ulnar osteotomy model. J Bone Joint Surg Am. 2001;83-A:1219-1230.
39. Leucht P, Minear S, Ten Berge D, Nusse R, Helms JA. Translating insights from development into regenerative medicine: The function of Wnts in bone biology. Semin Cell Dev Biol. 2008;19:434-443.
40. Kanatani M, Sugimoto T, Kaji H, et al. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity. J Bone Miner Res. 1995;10:1681-1690.
41. Yu H-MI, Jerchow B, Sheu T-J, et al. The role of Axin2 in calvarial morphogenesis and craniosynostosis. Development. 2005;132:1995-2005. (Pubitemid 40691787)
42. Liu B, Yu HM, Hsu W. Craniosynostosis caused by Axin2 deficiency is mediated through distinct functions of b-catenin in proliferation and differentiation. Dev Biol. 2007;301:298-308. (Pubitemid 44958400)
43. Collin P, Nefussi JR, Wetterwald A, et al. Expression of collagen, osteocalcin, and bone alkaline phosphatase in a mineralizing rat osteoblastic cell culture. Calcif Tissue Int. 1992;50:175-183.
44. Wada T, Nakashima T, Hiroshi N, Penninger JM. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med. 2006;12:17-25. (Pubitemid 43089652)
45. ten Berge D, Brugmann SA, Helms JA, Nusse R. Wnt and FGF signals interact to coordinate growth with cell fate specification during limb development. Development. 2008;135:3247-3257.
46. de Crombrugghe B, Lefebvre V, Behringer RR, Bi W, Murakami S, Huang W. Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol. 2000;19:389-394.
47. Bell DM, Leung KK, Wheatley SC, et al. SOX9 directly regulates the type-II collagen gene. Nature Genetics. 1997;16:174-178.
48. Mundlos S, Engel H, Michel-Behnke I, Zabel B. Distribution of type I and type II collagen gene expression during the development of human long bones. Bone. 1990;11:275-279. (Pubitemid 20318182)
49. Thompson Z, Miclau T, Hu D, Helms JA. A model for intramembranous ossification during fracture healing. J Orthop Res. 2002;20:1091-1098.
50. Goldring MB, Otero M, Tsuchimochi K, Ijiri K, Li Y. Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism. Ann Rheum Dis. 2008;67 (Suppl 3): iii75-82.
51. Sato M, Ochi T, Nakase T, et al. Mechanical tension-stress induces expression of bone morphogenetic protein (BMP)-2 and BMP-4, but not BMP-6, BMP-7, and GDF-5 mRNA, during distraction osteogenesis. J Bone Miner Res. 1999;14:1084-1095. (Pubitemid 29314051)
52. Colnot C. Skeletal Cell Fate Decisions Within Periosteum and Bone Marrow During Bone Regeneration. J Bone Miner Res. 2008;24:274-282.
53. Fuentealba LC, Eivers E, Ikeda A, et al. Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell. 2007;131:980-993. (Pubitemid 350138081)
54. Baker JC, Beddington RS, Harland RM. Wnt signaling in Xenopus embryos inhibits bmp4 expression and activates neural development. Genes Dev. 1999;13:3149-3159.
55. Rodda SJ, McMahon AP. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development. 2006;133:3231-3244.
56. Chen Y, Whetstone HC, Lin AC, et al. Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing. PLoS Med. 2007;4:e249.
57. Williams BO, Insogna KL. Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone. J Bone Miner Res. 2009;24:171-178.
58. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human marrow. Bone. 1992;13:81-88.
59. Sen MK, Miclau T. Autologous iliac crest bone graft: Should it still be the gold standard for treating nonunions? Injury. 2007;38 (Suppl 1): S75-80.
60. Diefenderfer DL, Osyczka AM, Garino JP, Leboy PS. Regulation of BMP-induced transcription in cultured human bone marrow stromal cells. J Bone Joint Surg Am. 2003;85-A (Suppl 3): 19-28. (Pubitemid 36957900)
61. Diefenderfer DL, Osyczka AM, Reilly GC, Leboy PS. BMP responsiveness in human mesenchymal stem cells. Connect Tissue Res. 2003;44 (Suppl 1): 305-311. (Pubitemid 36395462)
62. Osyczka AM, Diefenderfer DL, Bhargave G, Leboy PS. Different effects of BMP-2 on marrow stromal cells from human and rat bone. Cells Tissues Organs. 2004;176:109-119. (Pubitemid 38199424)
63. Jones AL, Bucholz RW, Bosse MJ, et al. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Joint Surg Am. 2006;88:1431-1441.
64. Gaur T, Lengner CJ, Hovhannisyan H, et al. Canonical WNT signaling promotes osteogenesis by directly stimulating runx2 gene expression. J Biol Chem. 2005;280:33132-33140. (Pubitemid 41397109)
65. Karsenty G, Ducy P, Starbuck M, et al. Cbfa1 as a regulator of osteoblast differentiation and function. Bone. 1999;25:107-108. (Pubitemid 29322071)
66. Semenov MV, He X. LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST. J Biol Chem. 2006.
67. Winkler DG, Sutherland MK, Geoghegan JC, et al. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. Embo J. 2003;22:6267-6276.
68. ten Dijke P, Krause C, de Gorter DJ, Lowik CW, van Bezooijen RL. Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling. J Bone Joint Surg Am. 2008;90 (Suppl 1): 31-35.
69. Zhang X, Xie C, Lin AS, et al. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. J Bone Miner Res. 2005;20:2124-2137.
70. Yamamoto M, Tabata Y, Ikada Y. Ectopic bone formation induced by biodegradable hydrogels incorporating bone morphogenetic protein. J Biomater Sci Polym Ed. 1998;9:439-458. (Pubitemid 28276650)
71. Engstrand T, Veltheim R, Arnander C, et al. A novel biodegradable delivery system for bone morphogenetic protein-2. Plast Reconstr Surg. 2008;121:1920-1928.
72. Taipaleenmaki H, Suomi S, Hentunen T, Laitala-Leinonen T, Saamanen AM. Impact of stromal cell composition on BMP-induced chondrogenic differentiation of mouse bone marrow derived mesenchymal cells. Exp Cell Res. 2008;314:2400-2410.